Global Drug Safety and Pharmacovigilance (PV) Software Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Drug Safety and Pharmacovigilance (PV) Software market size was valued at US$ 289 million in 2025 and is forecast to a readjusted size of US$ 411 million by 2032 with a CAGR of 5.1% during review period.
Drug Safety and Pharmacovigilance (PV) Software is an automated, information-based tool used by pharmaceutical companies, healthcare institutions, and regulatory authorities to monitor, assess, and prevent adverse drug reactions (ADRs) and safety risks throughout the entire drug lifecycle. It ensures drug compliance, aims to protect public health, improve patient safety, and meet the legal obligations of marketing authorization holders (MAHs).
As global drug regulatory agencies (such as the FDA, EMA, and NMPA) continue to tighten post-marketing regulatory requirements, the traditional manual review-based Individual Case Safety Report (ICSR) processing model can no longer cope with the explosive growth of massive amounts of data. Current leading opinions emphasize that by 2026, the core competitiveness of the market will focus on the full-stack integration capability of AI, that is, whether software can automate the entire process from scanning original documents and automatically sorting cases to providing scientific writing suggestions through large language models and natural language processing. This transformation makes pharmacovigilance software no longer just a database tool, but an indispensable 'risk warning center' in pharmaceutical companies' R&D decision-making.
This report is a detailed and comprehensive analysis for global Drug Safety and Pharmacovigilance (PV) Software market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Drug Safety and Pharmacovigilance (PV) Software market size and forecasts, in consumption value ($ Million), 2021-2032
Global Drug Safety and Pharmacovigilance (PV) Software market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Drug Safety and Pharmacovigilance (PV) Software market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Drug Safety and Pharmacovigilance (PV) Software market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Drug Safety and Pharmacovigilance (PV) Software market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Drug Safety and Pharmacovigilance (PV) Software product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Drug Safety and Pharmacovigilance (PV) Software, with revenue, gross margin, and global market share of Drug Safety and Pharmacovigilance (PV) Software from 2021 to 2026.
Chapter 3, the Drug Safety and Pharmacovigilance (PV) Software competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Drug Safety and Pharmacovigilance (PV) Software market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drug Safety and Pharmacovigilance (PV) Software.
Chapter 13, to describe Drug Safety and Pharmacovigilance (PV) Software research findings and conclusion.
Drug Safety and Pharmacovigilance (PV) Software is an automated, information-based tool used by pharmaceutical companies, healthcare institutions, and regulatory authorities to monitor, assess, and prevent adverse drug reactions (ADRs) and safety risks throughout the entire drug lifecycle. It ensures drug compliance, aims to protect public health, improve patient safety, and meet the legal obligations of marketing authorization holders (MAHs).
As global drug regulatory agencies (such as the FDA, EMA, and NMPA) continue to tighten post-marketing regulatory requirements, the traditional manual review-based Individual Case Safety Report (ICSR) processing model can no longer cope with the explosive growth of massive amounts of data. Current leading opinions emphasize that by 2026, the core competitiveness of the market will focus on the full-stack integration capability of AI, that is, whether software can automate the entire process from scanning original documents and automatically sorting cases to providing scientific writing suggestions through large language models and natural language processing. This transformation makes pharmacovigilance software no longer just a database tool, but an indispensable 'risk warning center' in pharmaceutical companies' R&D decision-making.
This report is a detailed and comprehensive analysis for global Drug Safety and Pharmacovigilance (PV) Software market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Drug Safety and Pharmacovigilance (PV) Software market size and forecasts, in consumption value ($ Million), 2021-2032
Global Drug Safety and Pharmacovigilance (PV) Software market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Drug Safety and Pharmacovigilance (PV) Software market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Drug Safety and Pharmacovigilance (PV) Software market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Drug Safety and Pharmacovigilance (PV) Software
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Drug Safety and Pharmacovigilance (PV) Software market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- On-Premises
- Cloud-Based
- Pre-market
- Post-market
- Security Database
- Signal Detection
- Compliance Report
- Other
- Pharma and Biotech Companies
- Contract Research Organizations (CROs)
- Business Process Outsourcing (BPO) Firms
- Other
- Oracle
- Veeva Systems
- ArisGlobal
- IQVIA
- EXTEDO
- RxLogix
- Ennov
- Uppsala Monitoring Centre
- Medidata
- Clarivate
- AB Cube
- Cloudbyz
- Cognizant Technology
- Taimei Technology
- eMedyun
- Bioknow
- Singedi Health
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Drug Safety and Pharmacovigilance (PV) Software product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Drug Safety and Pharmacovigilance (PV) Software, with revenue, gross margin, and global market share of Drug Safety and Pharmacovigilance (PV) Software from 2021 to 2026.
Chapter 3, the Drug Safety and Pharmacovigilance (PV) Software competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Drug Safety and Pharmacovigilance (PV) Software market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drug Safety and Pharmacovigilance (PV) Software.
Chapter 13, to describe Drug Safety and Pharmacovigilance (PV) Software research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Drug Safety and Pharmacovigilance (PV) Software by Type
1.3.1 Overview: Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Type in 2025
1.3.3 On-Premises
1.3.4 Cloud-Based
1.4 Classification of Drug Safety and Pharmacovigilance (PV) Software by Data Range
1.4.1 Overview: Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Data Range: 2021 Versus 2025 Versus 2032
1.4.2 Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Data Range in 2025
1.4.3 Pre-market
1.4.4 Post-market
1.5 Classification of Drug Safety and Pharmacovigilance (PV) Software by Functional Modules
1.5.1 Overview: Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Functional Modules: 2021 Versus 2025 Versus 2032
1.5.2 Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Functional Modules in 2025
1.5.3 Security Database
1.5.4 Signal Detection
1.5.5 Compliance Report
1.5.6 Other
1.6 Global Drug Safety and Pharmacovigilance (PV) Software Market by Application
1.6.1 Overview: Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Pharma and Biotech Companies
1.6.3 Contract Research Organizations (CROs)
1.6.4 Business Process Outsourcing (BPO) Firms
1.6.5 Other
1.7 Global Drug Safety and Pharmacovigilance (PV) Software Market Size & Forecast
1.8 Global Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast by Region
1.8.1 Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Region, (2021-2032)
1.8.3 North America Drug Safety and Pharmacovigilance (PV) Software Market Size and Prospect (2021-2032)
1.8.4 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size and Prospect (2021-2032)
1.8.6 South America Drug Safety and Pharmacovigilance (PV) Software Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Oracle
2.1.1 Oracle Details
2.1.2 Oracle Major Business
2.1.3 Oracle Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.1.4 Oracle Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Oracle Recent Developments and Future Plans
2.2 Veeva Systems
2.2.1 Veeva Systems Details
2.2.2 Veeva Systems Major Business
2.2.3 Veeva Systems Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.2.4 Veeva Systems Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Veeva Systems Recent Developments and Future Plans
2.3 ArisGlobal
2.3.1 ArisGlobal Details
2.3.2 ArisGlobal Major Business
2.3.3 ArisGlobal Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.3.4 ArisGlobal Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 ArisGlobal Recent Developments and Future Plans
2.4 IQVIA
2.4.1 IQVIA Details
2.4.2 IQVIA Major Business
2.4.3 IQVIA Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.4.4 IQVIA Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 IQVIA Recent Developments and Future Plans
2.5 EXTEDO
2.5.1 EXTEDO Details
2.5.2 EXTEDO Major Business
2.5.3 EXTEDO Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.5.4 EXTEDO Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 EXTEDO Recent Developments and Future Plans
2.6 RxLogix
2.6.1 RxLogix Details
2.6.2 RxLogix Major Business
2.6.3 RxLogix Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.6.4 RxLogix Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 RxLogix Recent Developments and Future Plans
2.7 Ennov
2.7.1 Ennov Details
2.7.2 Ennov Major Business
2.7.3 Ennov Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.7.4 Ennov Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Ennov Recent Developments and Future Plans
2.8 Uppsala Monitoring Centre
2.8.1 Uppsala Monitoring Centre Details
2.8.2 Uppsala Monitoring Centre Major Business
2.8.3 Uppsala Monitoring Centre Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.8.4 Uppsala Monitoring Centre Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Uppsala Monitoring Centre Recent Developments and Future Plans
2.9 Medidata
2.9.1 Medidata Details
2.9.2 Medidata Major Business
2.9.3 Medidata Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.9.4 Medidata Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Medidata Recent Developments and Future Plans
2.10 Clarivate
2.10.1 Clarivate Details
2.10.2 Clarivate Major Business
2.10.3 Clarivate Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.10.4 Clarivate Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Clarivate Recent Developments and Future Plans
2.11 AB Cube
2.11.1 AB Cube Details
2.11.2 AB Cube Major Business
2.11.3 AB Cube Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.11.4 AB Cube Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 AB Cube Recent Developments and Future Plans
2.12 Cloudbyz
2.12.1 Cloudbyz Details
2.12.2 Cloudbyz Major Business
2.12.3 Cloudbyz Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.12.4 Cloudbyz Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Cloudbyz Recent Developments and Future Plans
2.13 Cognizant Technology
2.13.1 Cognizant Technology Details
2.13.2 Cognizant Technology Major Business
2.13.3 Cognizant Technology Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.13.4 Cognizant Technology Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Cognizant Technology Recent Developments and Future Plans
2.14 Taimei Technology
2.14.1 Taimei Technology Details
2.14.2 Taimei Technology Major Business
2.14.3 Taimei Technology Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.14.4 Taimei Technology Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Taimei Technology Recent Developments and Future Plans
2.15 eMedyun
2.15.1 eMedyun Details
2.15.2 eMedyun Major Business
2.15.3 eMedyun Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.15.4 eMedyun Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 eMedyun Recent Developments and Future Plans
2.16 Bioknow
2.16.1 Bioknow Details
2.16.2 Bioknow Major Business
2.16.3 Bioknow Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.16.4 Bioknow Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Bioknow Recent Developments and Future Plans
2.17 Singedi Health
2.17.1 Singedi Health Details
2.17.2 Singedi Health Major Business
2.17.3 Singedi Health Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.17.4 Singedi Health Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Singedi Health Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Drug Safety and Pharmacovigilance (PV) Software Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Drug Safety and Pharmacovigilance (PV) Software by Company Revenue
3.2.2 Top 3 Drug Safety and Pharmacovigilance (PV) Software Players Market Share in 2025
3.2.3 Top 6 Drug Safety and Pharmacovigilance (PV) Software Players Market Share in 2025
3.3 Drug Safety and Pharmacovigilance (PV) Software Market: Overall Company Footprint Analysis
3.3.1 Drug Safety and Pharmacovigilance (PV) Software Market: Region Footprint
3.3.2 Drug Safety and Pharmacovigilance (PV) Software Market: Company Product Type Footprint
3.3.3 Drug Safety and Pharmacovigilance (PV) Software Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value and Market Share by Type (2021-2026)
4.2 Global Drug Safety and Pharmacovigilance (PV) Software Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Application (2021-2026)
5.2 Global Drug Safety and Pharmacovigilance (PV) Software Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type (2021-2032)
6.2 North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2021-2032)
6.3 North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country
6.3.1 North America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Country (2021-2032)
6.3.2 United States Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
6.3.3 Canada Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
6.3.4 Mexico Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type (2021-2032)
7.2 Europe Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application (2021-2032)
7.3 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Country
7.3.1 Europe Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Country (2021-2032)
7.3.2 Germany Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
7.3.3 France Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
7.3.5 Russia Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
7.3.6 Italy Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size by Region
8.3.1 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Region (2021-2032)
8.3.2 China Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
8.3.3 Japan Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
8.3.4 South Korea Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
8.3.5 India Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
8.3.7 Australia Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type (2021-2032)
9.2 South America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application (2021-2032)
9.3 South America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country
9.3.1 South America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Country (2021-2032)
9.3.2 Brazil Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
9.3.3 Argentina Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Country
10.3.1 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Country (2021-2032)
10.3.2 Turkey Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
10.3.4 UAE Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Drug Safety and Pharmacovigilance (PV) Software Market Drivers
11.2 Drug Safety and Pharmacovigilance (PV) Software Market Restraints
11.3 Drug Safety and Pharmacovigilance (PV) Software Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Drug Safety and Pharmacovigilance (PV) Software Industry Chain
12.2 Drug Safety and Pharmacovigilance (PV) Software Upstream Analysis
12.3 Drug Safety and Pharmacovigilance (PV) Software Midstream Analysis
12.4 Drug Safety and Pharmacovigilance (PV) Software Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Drug Safety and Pharmacovigilance (PV) Software by Type
1.3.1 Overview: Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Type in 2025
1.3.3 On-Premises
1.3.4 Cloud-Based
1.4 Classification of Drug Safety and Pharmacovigilance (PV) Software by Data Range
1.4.1 Overview: Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Data Range: 2021 Versus 2025 Versus 2032
1.4.2 Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Data Range in 2025
1.4.3 Pre-market
1.4.4 Post-market
1.5 Classification of Drug Safety and Pharmacovigilance (PV) Software by Functional Modules
1.5.1 Overview: Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Functional Modules: 2021 Versus 2025 Versus 2032
1.5.2 Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Functional Modules in 2025
1.5.3 Security Database
1.5.4 Signal Detection
1.5.5 Compliance Report
1.5.6 Other
1.6 Global Drug Safety and Pharmacovigilance (PV) Software Market by Application
1.6.1 Overview: Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Pharma and Biotech Companies
1.6.3 Contract Research Organizations (CROs)
1.6.4 Business Process Outsourcing (BPO) Firms
1.6.5 Other
1.7 Global Drug Safety and Pharmacovigilance (PV) Software Market Size & Forecast
1.8 Global Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast by Region
1.8.1 Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Region, (2021-2032)
1.8.3 North America Drug Safety and Pharmacovigilance (PV) Software Market Size and Prospect (2021-2032)
1.8.4 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size and Prospect (2021-2032)
1.8.6 South America Drug Safety and Pharmacovigilance (PV) Software Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Oracle
2.1.1 Oracle Details
2.1.2 Oracle Major Business
2.1.3 Oracle Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.1.4 Oracle Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Oracle Recent Developments and Future Plans
2.2 Veeva Systems
2.2.1 Veeva Systems Details
2.2.2 Veeva Systems Major Business
2.2.3 Veeva Systems Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.2.4 Veeva Systems Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Veeva Systems Recent Developments and Future Plans
2.3 ArisGlobal
2.3.1 ArisGlobal Details
2.3.2 ArisGlobal Major Business
2.3.3 ArisGlobal Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.3.4 ArisGlobal Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 ArisGlobal Recent Developments and Future Plans
2.4 IQVIA
2.4.1 IQVIA Details
2.4.2 IQVIA Major Business
2.4.3 IQVIA Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.4.4 IQVIA Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 IQVIA Recent Developments and Future Plans
2.5 EXTEDO
2.5.1 EXTEDO Details
2.5.2 EXTEDO Major Business
2.5.3 EXTEDO Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.5.4 EXTEDO Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 EXTEDO Recent Developments and Future Plans
2.6 RxLogix
2.6.1 RxLogix Details
2.6.2 RxLogix Major Business
2.6.3 RxLogix Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.6.4 RxLogix Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 RxLogix Recent Developments and Future Plans
2.7 Ennov
2.7.1 Ennov Details
2.7.2 Ennov Major Business
2.7.3 Ennov Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.7.4 Ennov Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Ennov Recent Developments and Future Plans
2.8 Uppsala Monitoring Centre
2.8.1 Uppsala Monitoring Centre Details
2.8.2 Uppsala Monitoring Centre Major Business
2.8.3 Uppsala Monitoring Centre Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.8.4 Uppsala Monitoring Centre Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Uppsala Monitoring Centre Recent Developments and Future Plans
2.9 Medidata
2.9.1 Medidata Details
2.9.2 Medidata Major Business
2.9.3 Medidata Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.9.4 Medidata Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Medidata Recent Developments and Future Plans
2.10 Clarivate
2.10.1 Clarivate Details
2.10.2 Clarivate Major Business
2.10.3 Clarivate Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.10.4 Clarivate Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Clarivate Recent Developments and Future Plans
2.11 AB Cube
2.11.1 AB Cube Details
2.11.2 AB Cube Major Business
2.11.3 AB Cube Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.11.4 AB Cube Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 AB Cube Recent Developments and Future Plans
2.12 Cloudbyz
2.12.1 Cloudbyz Details
2.12.2 Cloudbyz Major Business
2.12.3 Cloudbyz Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.12.4 Cloudbyz Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Cloudbyz Recent Developments and Future Plans
2.13 Cognizant Technology
2.13.1 Cognizant Technology Details
2.13.2 Cognizant Technology Major Business
2.13.3 Cognizant Technology Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.13.4 Cognizant Technology Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Cognizant Technology Recent Developments and Future Plans
2.14 Taimei Technology
2.14.1 Taimei Technology Details
2.14.2 Taimei Technology Major Business
2.14.3 Taimei Technology Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.14.4 Taimei Technology Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Taimei Technology Recent Developments and Future Plans
2.15 eMedyun
2.15.1 eMedyun Details
2.15.2 eMedyun Major Business
2.15.3 eMedyun Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.15.4 eMedyun Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 eMedyun Recent Developments and Future Plans
2.16 Bioknow
2.16.1 Bioknow Details
2.16.2 Bioknow Major Business
2.16.3 Bioknow Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.16.4 Bioknow Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Bioknow Recent Developments and Future Plans
2.17 Singedi Health
2.17.1 Singedi Health Details
2.17.2 Singedi Health Major Business
2.17.3 Singedi Health Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
2.17.4 Singedi Health Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Singedi Health Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Drug Safety and Pharmacovigilance (PV) Software Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Drug Safety and Pharmacovigilance (PV) Software by Company Revenue
3.2.2 Top 3 Drug Safety and Pharmacovigilance (PV) Software Players Market Share in 2025
3.2.3 Top 6 Drug Safety and Pharmacovigilance (PV) Software Players Market Share in 2025
3.3 Drug Safety and Pharmacovigilance (PV) Software Market: Overall Company Footprint Analysis
3.3.1 Drug Safety and Pharmacovigilance (PV) Software Market: Region Footprint
3.3.2 Drug Safety and Pharmacovigilance (PV) Software Market: Company Product Type Footprint
3.3.3 Drug Safety and Pharmacovigilance (PV) Software Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value and Market Share by Type (2021-2026)
4.2 Global Drug Safety and Pharmacovigilance (PV) Software Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Application (2021-2026)
5.2 Global Drug Safety and Pharmacovigilance (PV) Software Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type (2021-2032)
6.2 North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2021-2032)
6.3 North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country
6.3.1 North America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Country (2021-2032)
6.3.2 United States Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
6.3.3 Canada Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
6.3.4 Mexico Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type (2021-2032)
7.2 Europe Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application (2021-2032)
7.3 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Country
7.3.1 Europe Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Country (2021-2032)
7.3.2 Germany Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
7.3.3 France Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
7.3.5 Russia Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
7.3.6 Italy Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size by Region
8.3.1 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Region (2021-2032)
8.3.2 China Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
8.3.3 Japan Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
8.3.4 South Korea Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
8.3.5 India Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
8.3.7 Australia Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type (2021-2032)
9.2 South America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application (2021-2032)
9.3 South America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country
9.3.1 South America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Country (2021-2032)
9.3.2 Brazil Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
9.3.3 Argentina Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Country
10.3.1 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Country (2021-2032)
10.3.2 Turkey Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
10.3.4 UAE Drug Safety and Pharmacovigilance (PV) Software Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Drug Safety and Pharmacovigilance (PV) Software Market Drivers
11.2 Drug Safety and Pharmacovigilance (PV) Software Market Restraints
11.3 Drug Safety and Pharmacovigilance (PV) Software Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Drug Safety and Pharmacovigilance (PV) Software Industry Chain
12.2 Drug Safety and Pharmacovigilance (PV) Software Upstream Analysis
12.3 Drug Safety and Pharmacovigilance (PV) Software Midstream Analysis
12.4 Drug Safety and Pharmacovigilance (PV) Software Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Data Range, (USD Million), 2021 & 2025 & 2032
Table 3. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Functional Modules, (USD Million), 2021 & 2025 & 2032
Table 4. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Oracle Company Information, Head Office, and Major Competitors
Table 8. Oracle Major Business
Table 9. Oracle Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 10. Oracle Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Oracle Recent Developments and Future Plans
Table 12. Veeva Systems Company Information, Head Office, and Major Competitors
Table 13. Veeva Systems Major Business
Table 14. Veeva Systems Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 15. Veeva Systems Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Veeva Systems Recent Developments and Future Plans
Table 17. ArisGlobal Company Information, Head Office, and Major Competitors
Table 18. ArisGlobal Major Business
Table 19. ArisGlobal Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 20. ArisGlobal Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. IQVIA Company Information, Head Office, and Major Competitors
Table 22. IQVIA Major Business
Table 23. IQVIA Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 24. IQVIA Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. IQVIA Recent Developments and Future Plans
Table 26. EXTEDO Company Information, Head Office, and Major Competitors
Table 27. EXTEDO Major Business
Table 28. EXTEDO Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 29. EXTEDO Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. EXTEDO Recent Developments and Future Plans
Table 31. RxLogix Company Information, Head Office, and Major Competitors
Table 32. RxLogix Major Business
Table 33. RxLogix Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 34. RxLogix Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. RxLogix Recent Developments and Future Plans
Table 36. Ennov Company Information, Head Office, and Major Competitors
Table 37. Ennov Major Business
Table 38. Ennov Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 39. Ennov Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Ennov Recent Developments and Future Plans
Table 41. Uppsala Monitoring Centre Company Information, Head Office, and Major Competitors
Table 42. Uppsala Monitoring Centre Major Business
Table 43. Uppsala Monitoring Centre Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 44. Uppsala Monitoring Centre Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Uppsala Monitoring Centre Recent Developments and Future Plans
Table 46. Medidata Company Information, Head Office, and Major Competitors
Table 47. Medidata Major Business
Table 48. Medidata Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 49. Medidata Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Medidata Recent Developments and Future Plans
Table 51. Clarivate Company Information, Head Office, and Major Competitors
Table 52. Clarivate Major Business
Table 53. Clarivate Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 54. Clarivate Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Clarivate Recent Developments and Future Plans
Table 56. AB Cube Company Information, Head Office, and Major Competitors
Table 57. AB Cube Major Business
Table 58. AB Cube Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 59. AB Cube Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. AB Cube Recent Developments and Future Plans
Table 61. Cloudbyz Company Information, Head Office, and Major Competitors
Table 62. Cloudbyz Major Business
Table 63. Cloudbyz Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 64. Cloudbyz Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Cloudbyz Recent Developments and Future Plans
Table 66. Cognizant Technology Company Information, Head Office, and Major Competitors
Table 67. Cognizant Technology Major Business
Table 68. Cognizant Technology Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 69. Cognizant Technology Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Cognizant Technology Recent Developments and Future Plans
Table 71. Taimei Technology Company Information, Head Office, and Major Competitors
Table 72. Taimei Technology Major Business
Table 73. Taimei Technology Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 74. Taimei Technology Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Taimei Technology Recent Developments and Future Plans
Table 76. eMedyun Company Information, Head Office, and Major Competitors
Table 77. eMedyun Major Business
Table 78. eMedyun Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 79. eMedyun Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. eMedyun Recent Developments and Future Plans
Table 81. Bioknow Company Information, Head Office, and Major Competitors
Table 82. Bioknow Major Business
Table 83. Bioknow Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 84. Bioknow Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Bioknow Recent Developments and Future Plans
Table 86. Singedi Health Company Information, Head Office, and Major Competitors
Table 87. Singedi Health Major Business
Table 88. Singedi Health Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 89. Singedi Health Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Singedi Health Recent Developments and Future Plans
Table 91. Global Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million) by Players (2021-2026)
Table 92. Global Drug Safety and Pharmacovigilance (PV) Software Revenue Share by Players (2021-2026)
Table 93. Breakdown of Drug Safety and Pharmacovigilance (PV) Software by Company Type (Tier 1, Tier 2, and Tier 3)
Table 94. Market Position of Players in Drug Safety and Pharmacovigilance (PV) Software, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 95. Head Office of Key Drug Safety and Pharmacovigilance (PV) Software Players
Table 96. Drug Safety and Pharmacovigilance (PV) Software Market: Company Product Type Footprint
Table 97. Drug Safety and Pharmacovigilance (PV) Software Market: Company Product Application Footprint
Table 98. Drug Safety and Pharmacovigilance (PV) Software New Market Entrants and Barriers to Market Entry
Table 99. Drug Safety and Pharmacovigilance (PV) Software Mergers, Acquisition, Agreements, and Collaborations
Table 100. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value (USD Million) by Type (2021-2026)
Table 101. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value Share by Type (2021-2026)
Table 102. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value Forecast by Type (2027-2032)
Table 103. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application (2021-2026)
Table 104. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value Forecast by Application (2027-2032)
Table 105. North America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type (2021-2026) & (USD Million)
Table 106. North America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type (2027-2032) & (USD Million)
Table 107. North America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application (2021-2026) & (USD Million)
Table 108. North America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application (2027-2032) & (USD Million)
Table 109. North America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Country (2021-2026) & (USD Million)
Table 110. North America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Country (2027-2032) & (USD Million)
Table 111. Europe Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type (2021-2026) & (USD Million)
Table 112. Europe Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type (2027-2032) & (USD Million)
Table 113. Europe Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application (2021-2026) & (USD Million)
Table 114. Europe Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application (2027-2032) & (USD Million)
Table 115. Europe Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Country (2021-2026) & (USD Million)
Table 116. Europe Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Country (2027-2032) & (USD Million)
Table 117. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type (2021-2026) & (USD Million)
Table 118. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type (2027-2032) & (USD Million)
Table 119. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application (2021-2026) & (USD Million)
Table 120. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application (2027-2032) & (USD Million)
Table 121. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Region (2021-2026) & (USD Million)
Table 122. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Region (2027-2032) & (USD Million)
Table 123. South America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type (2021-2026) & (USD Million)
Table 124. South America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type (2027-2032) & (USD Million)
Table 125. South America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application (2021-2026) & (USD Million)
Table 126. South America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application (2027-2032) & (USD Million)
Table 127. South America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Country (2021-2026) & (USD Million)
Table 128. South America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Country (2027-2032) & (USD Million)
Table 129. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type (2021-2026) & (USD Million)
Table 130. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type (2027-2032) & (USD Million)
Table 131. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application (2021-2026) & (USD Million)
Table 132. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application (2027-2032) & (USD Million)
Table 133. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Country (2021-2026) & (USD Million)
Table 134. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Country (2027-2032) & (USD Million)
Table 135. Global Key Players of Drug Safety and Pharmacovigilance (PV) Software Upstream (Raw Materials)
Table 136. Global Drug Safety and Pharmacovigilance (PV) Software Typical Customers
Table 1. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Data Range, (USD Million), 2021 & 2025 & 2032
Table 3. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Functional Modules, (USD Million), 2021 & 2025 & 2032
Table 4. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Oracle Company Information, Head Office, and Major Competitors
Table 8. Oracle Major Business
Table 9. Oracle Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 10. Oracle Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Oracle Recent Developments and Future Plans
Table 12. Veeva Systems Company Information, Head Office, and Major Competitors
Table 13. Veeva Systems Major Business
Table 14. Veeva Systems Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 15. Veeva Systems Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Veeva Systems Recent Developments and Future Plans
Table 17. ArisGlobal Company Information, Head Office, and Major Competitors
Table 18. ArisGlobal Major Business
Table 19. ArisGlobal Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 20. ArisGlobal Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. IQVIA Company Information, Head Office, and Major Competitors
Table 22. IQVIA Major Business
Table 23. IQVIA Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 24. IQVIA Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. IQVIA Recent Developments and Future Plans
Table 26. EXTEDO Company Information, Head Office, and Major Competitors
Table 27. EXTEDO Major Business
Table 28. EXTEDO Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 29. EXTEDO Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. EXTEDO Recent Developments and Future Plans
Table 31. RxLogix Company Information, Head Office, and Major Competitors
Table 32. RxLogix Major Business
Table 33. RxLogix Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 34. RxLogix Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. RxLogix Recent Developments and Future Plans
Table 36. Ennov Company Information, Head Office, and Major Competitors
Table 37. Ennov Major Business
Table 38. Ennov Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 39. Ennov Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Ennov Recent Developments and Future Plans
Table 41. Uppsala Monitoring Centre Company Information, Head Office, and Major Competitors
Table 42. Uppsala Monitoring Centre Major Business
Table 43. Uppsala Monitoring Centre Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 44. Uppsala Monitoring Centre Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Uppsala Monitoring Centre Recent Developments and Future Plans
Table 46. Medidata Company Information, Head Office, and Major Competitors
Table 47. Medidata Major Business
Table 48. Medidata Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 49. Medidata Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Medidata Recent Developments and Future Plans
Table 51. Clarivate Company Information, Head Office, and Major Competitors
Table 52. Clarivate Major Business
Table 53. Clarivate Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 54. Clarivate Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Clarivate Recent Developments and Future Plans
Table 56. AB Cube Company Information, Head Office, and Major Competitors
Table 57. AB Cube Major Business
Table 58. AB Cube Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 59. AB Cube Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. AB Cube Recent Developments and Future Plans
Table 61. Cloudbyz Company Information, Head Office, and Major Competitors
Table 62. Cloudbyz Major Business
Table 63. Cloudbyz Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 64. Cloudbyz Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Cloudbyz Recent Developments and Future Plans
Table 66. Cognizant Technology Company Information, Head Office, and Major Competitors
Table 67. Cognizant Technology Major Business
Table 68. Cognizant Technology Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 69. Cognizant Technology Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Cognizant Technology Recent Developments and Future Plans
Table 71. Taimei Technology Company Information, Head Office, and Major Competitors
Table 72. Taimei Technology Major Business
Table 73. Taimei Technology Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 74. Taimei Technology Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Taimei Technology Recent Developments and Future Plans
Table 76. eMedyun Company Information, Head Office, and Major Competitors
Table 77. eMedyun Major Business
Table 78. eMedyun Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 79. eMedyun Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. eMedyun Recent Developments and Future Plans
Table 81. Bioknow Company Information, Head Office, and Major Competitors
Table 82. Bioknow Major Business
Table 83. Bioknow Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 84. Bioknow Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Bioknow Recent Developments and Future Plans
Table 86. Singedi Health Company Information, Head Office, and Major Competitors
Table 87. Singedi Health Major Business
Table 88. Singedi Health Drug Safety and Pharmacovigilance (PV) Software Product and Solutions
Table 89. Singedi Health Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Singedi Health Recent Developments and Future Plans
Table 91. Global Drug Safety and Pharmacovigilance (PV) Software Revenue (USD Million) by Players (2021-2026)
Table 92. Global Drug Safety and Pharmacovigilance (PV) Software Revenue Share by Players (2021-2026)
Table 93. Breakdown of Drug Safety and Pharmacovigilance (PV) Software by Company Type (Tier 1, Tier 2, and Tier 3)
Table 94. Market Position of Players in Drug Safety and Pharmacovigilance (PV) Software, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 95. Head Office of Key Drug Safety and Pharmacovigilance (PV) Software Players
Table 96. Drug Safety and Pharmacovigilance (PV) Software Market: Company Product Type Footprint
Table 97. Drug Safety and Pharmacovigilance (PV) Software Market: Company Product Application Footprint
Table 98. Drug Safety and Pharmacovigilance (PV) Software New Market Entrants and Barriers to Market Entry
Table 99. Drug Safety and Pharmacovigilance (PV) Software Mergers, Acquisition, Agreements, and Collaborations
Table 100. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value (USD Million) by Type (2021-2026)
Table 101. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value Share by Type (2021-2026)
Table 102. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value Forecast by Type (2027-2032)
Table 103. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application (2021-2026)
Table 104. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value Forecast by Application (2027-2032)
Table 105. North America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type (2021-2026) & (USD Million)
Table 106. North America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type (2027-2032) & (USD Million)
Table 107. North America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application (2021-2026) & (USD Million)
Table 108. North America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application (2027-2032) & (USD Million)
Table 109. North America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Country (2021-2026) & (USD Million)
Table 110. North America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Country (2027-2032) & (USD Million)
Table 111. Europe Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type (2021-2026) & (USD Million)
Table 112. Europe Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type (2027-2032) & (USD Million)
Table 113. Europe Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application (2021-2026) & (USD Million)
Table 114. Europe Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application (2027-2032) & (USD Million)
Table 115. Europe Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Country (2021-2026) & (USD Million)
Table 116. Europe Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Country (2027-2032) & (USD Million)
Table 117. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type (2021-2026) & (USD Million)
Table 118. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type (2027-2032) & (USD Million)
Table 119. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application (2021-2026) & (USD Million)
Table 120. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application (2027-2032) & (USD Million)
Table 121. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Region (2021-2026) & (USD Million)
Table 122. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Region (2027-2032) & (USD Million)
Table 123. South America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type (2021-2026) & (USD Million)
Table 124. South America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type (2027-2032) & (USD Million)
Table 125. South America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application (2021-2026) & (USD Million)
Table 126. South America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application (2027-2032) & (USD Million)
Table 127. South America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Country (2021-2026) & (USD Million)
Table 128. South America Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Country (2027-2032) & (USD Million)
Table 129. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type (2021-2026) & (USD Million)
Table 130. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type (2027-2032) & (USD Million)
Table 131. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application (2021-2026) & (USD Million)
Table 132. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application (2027-2032) & (USD Million)
Table 133. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Country (2021-2026) & (USD Million)
Table 134. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Country (2027-2032) & (USD Million)
Table 135. Global Key Players of Drug Safety and Pharmacovigilance (PV) Software Upstream (Raw Materials)
Table 136. Global Drug Safety and Pharmacovigilance (PV) Software Typical Customers
LIST OF FIGURES
Figure 1. Drug Safety and Pharmacovigilance (PV) Software Picture
Figure 2. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Type in 2025
Figure 4. On-Premises
Figure 5. Cloud-Based
Figure 6. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Data Range, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Data Range in 2025
Figure 8. Pre-market
Figure 9. Post-market
Figure 10. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Functional Modules, (USD Million), 2021 & 2025 & 2032
Figure 11. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Functional Modules in 2025
Figure 12. Security Database
Figure 13. Signal Detection
Figure 14. Compliance Report
Figure 15. Other
Figure 16. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 17. Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Application in 2025
Figure 18. Pharma and Biotech Companies Picture
Figure 19. Contract Research Organizations (CROs) Picture
Figure 20. Business Process Outsourcing (BPO) Firms Picture
Figure 21. Other Picture
Figure 22. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 23. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 24. Global Market Drug Safety and Pharmacovigilance (PV) Software Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 25. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Region (2021-2032)
Figure 26. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Region in 2025
Figure 27. North America Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 28. Europe Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 29. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 30. South America Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 31. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 32. Company Three Recent Developments and Future Plans
Figure 33. Global Drug Safety and Pharmacovigilance (PV) Software Revenue Share by Players in 2025
Figure 34. Drug Safety and Pharmacovigilance (PV) Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 35. Market Share of Drug Safety and Pharmacovigilance (PV) Software by Player Revenue in 2025
Figure 36. Top 3 Drug Safety and Pharmacovigilance (PV) Software Players Market Share in 2025
Figure 37. Top 6 Drug Safety and Pharmacovigilance (PV) Software Players Market Share in 2025
Figure 38. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value Share by Type (2021-2026)
Figure 39. Global Drug Safety and Pharmacovigilance (PV) Software Market Share Forecast by Type (2027-2032)
Figure 40. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value Share by Application (2021-2026)
Figure 41. Global Drug Safety and Pharmacovigilance (PV) Software Market Share Forecast by Application (2027-2032)
Figure 42. North America Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Type (2021-2032)
Figure 43. North America Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Application (2021-2032)
Figure 44. North America Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Country (2021-2032)
Figure 45. United States Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 46. Canada Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 47. Mexico Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 48. Europe Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Type (2021-2032)
Figure 49. Europe Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Application (2021-2032)
Figure 50. Europe Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Country (2021-2032)
Figure 51. Germany Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 52. France Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 53. United Kingdom Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 54. Russia Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 55. Italy Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 56. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Type (2021-2032)
Figure 57. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Application (2021-2032)
Figure 58. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Region (2021-2032)
Figure 59. China Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 60. Japan Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 61. South Korea Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 62. India Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 63. Southeast Asia Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 64. Australia Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 65. South America Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Type (2021-2032)
Figure 66. South America Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Application (2021-2032)
Figure 67. South America Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Country (2021-2032)
Figure 68. Brazil Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 69. Argentina Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 70. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Type (2021-2032)
Figure 71. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Application (2021-2032)
Figure 72. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Country (2021-2032)
Figure 73. Turkey Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 74. Saudi Arabia Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 75. UAE Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 76. Drug Safety and Pharmacovigilance (PV) Software Market Drivers
Figure 77. Drug Safety and Pharmacovigilance (PV) Software Market Restraints
Figure 78. Drug Safety and Pharmacovigilance (PV) Software Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Drug Safety and Pharmacovigilance (PV) Software Industrial Chain
Figure 81. Methodology
Figure 82. Research Process and Data Source
Figure 1. Drug Safety and Pharmacovigilance (PV) Software Picture
Figure 2. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Type in 2025
Figure 4. On-Premises
Figure 5. Cloud-Based
Figure 6. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Data Range, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Data Range in 2025
Figure 8. Pre-market
Figure 9. Post-market
Figure 10. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Functional Modules, (USD Million), 2021 & 2025 & 2032
Figure 11. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Functional Modules in 2025
Figure 12. Security Database
Figure 13. Signal Detection
Figure 14. Compliance Report
Figure 15. Other
Figure 16. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 17. Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Application in 2025
Figure 18. Pharma and Biotech Companies Picture
Figure 19. Contract Research Organizations (CROs) Picture
Figure 20. Business Process Outsourcing (BPO) Firms Picture
Figure 21. Other Picture
Figure 22. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 23. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 24. Global Market Drug Safety and Pharmacovigilance (PV) Software Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 25. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Region (2021-2032)
Figure 26. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Region in 2025
Figure 27. North America Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 28. Europe Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 29. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 30. South America Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 31. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 32. Company Three Recent Developments and Future Plans
Figure 33. Global Drug Safety and Pharmacovigilance (PV) Software Revenue Share by Players in 2025
Figure 34. Drug Safety and Pharmacovigilance (PV) Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 35. Market Share of Drug Safety and Pharmacovigilance (PV) Software by Player Revenue in 2025
Figure 36. Top 3 Drug Safety and Pharmacovigilance (PV) Software Players Market Share in 2025
Figure 37. Top 6 Drug Safety and Pharmacovigilance (PV) Software Players Market Share in 2025
Figure 38. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value Share by Type (2021-2026)
Figure 39. Global Drug Safety and Pharmacovigilance (PV) Software Market Share Forecast by Type (2027-2032)
Figure 40. Global Drug Safety and Pharmacovigilance (PV) Software Consumption Value Share by Application (2021-2026)
Figure 41. Global Drug Safety and Pharmacovigilance (PV) Software Market Share Forecast by Application (2027-2032)
Figure 42. North America Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Type (2021-2032)
Figure 43. North America Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Application (2021-2032)
Figure 44. North America Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Country (2021-2032)
Figure 45. United States Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 46. Canada Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 47. Mexico Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 48. Europe Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Type (2021-2032)
Figure 49. Europe Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Application (2021-2032)
Figure 50. Europe Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Country (2021-2032)
Figure 51. Germany Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 52. France Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 53. United Kingdom Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 54. Russia Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 55. Italy Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 56. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Type (2021-2032)
Figure 57. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Application (2021-2032)
Figure 58. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Region (2021-2032)
Figure 59. China Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 60. Japan Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 61. South Korea Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 62. India Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 63. Southeast Asia Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 64. Australia Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 65. South America Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Type (2021-2032)
Figure 66. South America Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Application (2021-2032)
Figure 67. South America Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Country (2021-2032)
Figure 68. Brazil Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 69. Argentina Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 70. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Type (2021-2032)
Figure 71. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Application (2021-2032)
Figure 72. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Consumption Value Market Share by Country (2021-2032)
Figure 73. Turkey Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 74. Saudi Arabia Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 75. UAE Drug Safety and Pharmacovigilance (PV) Software Consumption Value (2021-2032) & (USD Million)
Figure 76. Drug Safety and Pharmacovigilance (PV) Software Market Drivers
Figure 77. Drug Safety and Pharmacovigilance (PV) Software Market Restraints
Figure 78. Drug Safety and Pharmacovigilance (PV) Software Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Drug Safety and Pharmacovigilance (PV) Software Industrial Chain
Figure 81. Methodology
Figure 82. Research Process and Data Source
